# Safety, Tolerability, and Pharmacokinetic Study of Methylene Blue Following a 1 mg/kg Intravenous Dose in Healthy Adults

> **NCT02478281** · PHASE1 · COMPLETED · sponsor: **American Regent, Inc.** · enrollment: 12 (actual)

## Conditions studied

- Methemoglobinemia
- Congenital Methemoglobinemia

## Interventions

- **DRUG:** Methylene Blue

## Key facts

- **NCT ID:** NCT02478281
- **Lead sponsor:** American Regent, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2012-10
- **Final completion:** 2013-03
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02478281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02478281, "Safety, Tolerability, and Pharmacokinetic Study of Methylene Blue Following a 1 mg/kg Intravenous Dose in Healthy Adults". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02478281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*